Cite

HARVARD Citation

    Kiyosue, A. et al. (n.d.). Dose‐ranging study with the glucokinase activator AZD1656 as monotherapy in Japanese patients with type 2 diabetes mellitus. Diabetes, obesity & metabolism. 15 (10), pp. 923-930. [Online]. 
  
Back to record